<?xml version="1.0" encoding="UTF-8"?>
<rss version="2.0"><channel><title>Popular antidepressant recalled for high levels of a potentially cancer-causing chemical - KOLN — Live Feed</title><link>https://www.live-feeds.com/feed/popular-antidepressant-recalled-for-high-levels-of-a-potentially-cancer-causing-chemical-koln</link><atom:link xmlns:atom="http://www.w3.org/2005/Atom" href="https://www.live-feeds.com/feed/popular-antidepressant-recalled-for-high-levels-of-a-potentially-cancer-causing-chemical-koln/rss.xml" rel="self" type="application/rss+xml"/><description>Continuously updated, source-cited coverage.</description>
<item><title>Breckenridge Pharmaceuticals Recalls Duloxetine Over Cancer-Causing Impurity</title><link>https://www.live-feeds.com/feed/popular-antidepressant-recalled-for-high-levels-of-a-potentially-cancer-causing-chemical-koln</link><guid isPermaLink="false">https://www.live-feeds.com/feed/popular-antidepressant-recalled-for-high-levels-of-a-potentially-cancer-causing-chemical-koln#u11565</guid><pubDate>Wed, 24 Jun 2026 16:52:03 +0000</pubDate><description>Breckenridge Pharmaceuticals is recalling nearly 375,000 bottles of duloxetine nationwide. Tests found elevated levels of a nitrosamine impurity that may cause cancer. The drug is a generic version of Cymbalta used for depression, anxiety, and fibromyalgia.What's confirmed:Nearly 375,000 bottles of duloxetine are being recalled nationwide.The recall was triggered by elevated levels of a potentially cancer-causing nitrosamine impurity.The drug is used to treat anxiety, depression, and fibromyalgia.Breckenridge Pharmaceuticals is the New Jersey-based company recalling the generic version of Cymb</description></item>
<item><title>FDA Announces Recall of Popular Antidepressant Over Carcinogen Risk</title><link>https://www.live-feeds.com/feed/popular-antidepressant-recalled-for-high-levels-of-a-potentially-cancer-causing-chemical-koln</link><guid isPermaLink="false">https://www.live-feeds.com/feed/popular-antidepressant-recalled-for-high-levels-of-a-potentially-cancer-causing-chemical-koln#u7980</guid><pubDate>Mon, 22 Jun 2026 06:25:41 +0000</pubDate><description>The FDA announced a recall of a common antidepressant due to high levels of a potentially cancer-causing chemical. The medication is used to treat anxiety, depression, and fibromyalgia. Nearly 375,000 bottles are affected.What's confirmed:The FDA announced a recall of a popular antidepressant due to a possible carcinogen risk.The recall involves nearly 375,000 bottles of the medication.The drug is used to treat fibromyalgia, anxiety, and depression.The distributor voluntarily recalled the medication after detecting high levels of a potentially cancer-causing chemical.</description></item>
</channel></rss>